Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 5 recruiting now early-phase tilt small index

Cancer Patients: early-phase trial registry

5 of 9 indexed Cancer Patients trials are currently recruiting, with more weight in Phase 1-2.

Corpus placement: #1,916 of 28,707 conditions by registered trial count.

9 US clinical trials · 5 currently recruiting · #1,916 of 28,707 conditions by registered trial count

Cancer Patients: 9 US clinical trials tracked, 5 recruiting.

Cancer Patients is the subject of 9 registered US clinical trials on ClinicalTrials.gov, 5 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 2 in Phase 1-2 (earlier-stage). The most active sponsor is Memorial Sloan Kettering Cancer Center, running 5 of these trials.

Enrollment posture brief

Registry condition cancer-patients

OPEN 5 | RECR 56% | LATE 0 | EARLY 2 | RANK #1916 | SPON 5

Nearest open-share peer: Advanced Colorectal Cancer (56% recruiting · 9 trials)

Cancer Patients (this)56%Acute Lymphoblastic Leukemia55.6%Acute Respiratory Distress S55.6%Acute Otitis Media22.2%Acute Heart Failure11.1%
Open-enrollment share among volume-matched conditions near Cancer Patients

Cancer Patients lists 5 open slots (56% of 9 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Cancer Patients on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Cancer Patients is recruiting above its size-band peers.

    5 of 9 indexed trials (55.6%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. One sponsor concentrates Cancer Patients research.

    Memorial Sloan Kettering Cancer Center accounts for 5 of 9 trials (55.6%). 5 distinct sponsors appear on at least one study for this condition label.

  3. Typical Cancer Patients enrolment sits around 150 participants.

    Median target enrolment is 150 among the 9 trials that report a genuine target (sentinel values excluded). 4 of those (44.4%) plan for fewer than 100 participants.

  4. Cancer Patients research is mostly interventional.

    7 interventional and 2 observational studies make up this index (77.8% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 11Phase 21

Phase Distribution

PhaseTrial count
Phase 1 1
Phase 2 1

Named interventions

Most-linked intervention names on Cancer Patients records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Bright IDEAS-YA Behavioral
1 trials
Emotion Regulation Therapy for Cancer Caregivers (ERT-C) Other
1 trials
Cognitive Behavioral Therapy for Cancer Caregivers (CBT-C) Other
1 trials
Focus groups Behavioral
1 trials
Writing Behavioral
1 trials
PET/CT imaging Device
1 trials
Managing Anxiety from Cancer (MAC) Other
1 trials
surveys Behavioral
1 trials

US sites by state

Facility locations filed on Cancer Patients trials. A trial with sites in several states counts in each.

New York 7 trials
New Jersey 4 trials
Tennessee 1 trials
Nevada 1 trials
Massachusetts 1 trials
Florida 1 trials
California 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Cancer Patients page

9 registered trials, 5 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Cancer Patients condition card totals 9 registered trials; most-linked intervention Bright IDEAS-YA; top US site state New York. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.